Literature DB >> 9129744

Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities.

C A Moore1, H V Toriello, D N Abuelo, M J Bull, C J Curry, B D Hall, J V Higgins, C A Stevens, S Twersky, R Weksberg, W B Dobyns.   

Abstract

We describe 13 unrelated children with abnormalities of somatic growth, face, brain, and connective tissue including vasculature. Although the condition in these children falls under the general group of disorders known as cutis marmorata telangiectatica congenita (CMTC), the constellation of abnormalities appears to constitute a distinct and easily recognizable phenotype within this general group. In contrast to most children reported with CMTC, children in this subgroup have a high risk for neurologic abnormalities, including developmental delay, mental retardation, megalencephaly, and hydrocephalus. Early recognition of this condition is important for appropriate surveillance for known complications and parental counseling.

Entities:  

Mesh:

Year:  1997        PMID: 9129744

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  24 in total

1.  Consistent chromosome abnormalities identify novel polymicrogyria loci in 1p36.3, 2p16.1-p23.1, 4q21.21-q22.1, 6q26-q27, and 21q2.

Authors:  William B Dobyns; Ghayda Mirzaa; Susan L Christian; Kristin Petras; Jessica Roseberry; Gary D Clark; Cynthia J R Curry; Donna McDonald-McGinn; Livija Medne; Elaine Zackai; Julie Parsons; Dina J Zand; Fuki M Hisama; Christopher A Walsh; Richard J Leventer; Christa L Martin; Marzena Gajecka; Lisa G Shaffer
Journal:  Am J Med Genet A       Date:  2008-07-01       Impact factor: 2.802

2.  The microcephaly-capillary malformation syndrome.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Christopher D Smyser; Marcia C Willing; Anne C Lind; William B Dobyns
Journal:  Am J Med Genet A       Date:  2011-08-03       Impact factor: 2.802

Review 3.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

4.  Tetralogy of Fallot associated with macrocephaly-capillary malformation syndrome: a case report and review of the literature.

Authors:  Jesus E Dueñas-Arias; Eliakym Arámbula-Meraz; Luis O Frías-Castro; Rosalio Ramos-Payán; Jose A Quibrera-Matienzo; Fred Luque-Ortega; E Maribel Aguilar-Medina
Journal:  J Med Case Rep       Date:  2009-09-08

Review 5.  Neurocutaneous vascular syndromes.

Authors:  Katherine B Puttgen; Doris D M Lin
Journal:  Childs Nerv Syst       Date:  2010-06-27       Impact factor: 1.475

6.  Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?

Authors:  Dennis Döcker; Max Schubach; Moritz Menzel; Christiane Spaich; Heinz-Dieter Gabriel; Martin Zenker; Deborah Bartholdi; Saskia Biskup
Journal:  Eur J Hum Genet       Date:  2014-06-18       Impact factor: 4.246

Review 7.  Genetic considerations in the prenatal diagnosis of overgrowth syndromes.

Authors:  Neeta Vora; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2009-10       Impact factor: 3.050

Review 8.  Current concepts of polymicrogyria.

Authors:  A James Barkovich
Journal:  Neuroradiology       Date:  2010-03-03       Impact factor: 2.804

9.  Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients.

Authors:  Robert L Conway; Barry D Pressman; William B Dobyns; Moise Danielpour; John Lee; Pedro A Sanchez-Lara; Merlin G Butler; Elaine Zackai; Lindsey Campbell; Sulagna C Saitta; Carol L Clericuzio; Jeff M Milunsky; H Eugene Hoyme; Joseph Shieh; John B Moeschler; Barbara Crandall; Julie L Lauzon; David H Viskochil; Brian Harding; John M Graham
Journal:  Am J Med Genet A       Date:  2007-12-15       Impact factor: 2.802

10.  Cutis marmorata telangiectatica congenita with skin ulcerations in a new born.

Authors:  Rita Chatterjee; Subhendu Dey
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.